null

Associate Professor Eric Chun Yong CHAN

BSc (Pharm) (Hons), PhD, National University of Singapore

Department of Pharmacy, National University of Singapore
18 Science Drive 4, Singapore 117543
Tel: +65 6516 6137
Fax: +65 6779 1554
Email: eric.chan@nus.edu.sg
rg-mprg-fbico rg-mprg-gsico rg-mprg-rgico rg-mprg-rgicomprg-logo-small

Eric Chan is a pharmaceutical scientist and an associate professor in the Department of Pharmacy, National University of Singapore (NUS). His main research interests are:

  1. metabolism-driven systems biology modeling of diseases, pharmacology and toxicology, and
  2. xenobiotic-derived reactive metabolite research with specific focus on interaction with CYP450 enzymes, metabolic pathway regulation, protein glutathionylation and physiological-based pharmacokinetics (PBPK) modeling of pharmacology and toxicology.

Eric has been appointed the Dean’s Chair Professorship in the Faculty of Science from 2015-2018. He is currently a member of the Faculty Promotion and Tenure Committee (FPTC, 2016-2018) and an adjunct investigator at the Singapore Institute for Clinical Sciences (SICS, 2016-2019). He was Chair of Safety Committee from 2008-2011, Assistant Dean (Undergraduate Programmes) from 2011-2013 and Vice Dean (Undergraduate Studies and Student Life) from 2013-2014. He was thrice a recipient of both the Faculty of Science Teaching Excellence Award and NUS Annual Teaching Excellence Award and received the Faculty of Science Young Scientist Award (2010) and Outstanding Scientist Award (2014). Eric has received the NUS Overseas Attachment Programme and the National Medical Research Council awards for his overseas fellowships at the Imperial College London and University of Washington respectively.

He is an editorial board member of Journal of Chromatography B (Elsevier) and Journal of Proteome Research (ACS) and the grant review board member and referee panel for the Health and Medical Research Fund (HMRF) in Hong Kong. He is also the Scientific Affairs Committee member of the International Society for the Study of Xenobiotics (ISSX) and a member of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Eric is a registered pharmacist under the Singapore Pharmacy Council, Ministry of Health.

Prior to joining NUS, Eric worked as Senior Manager (Market Development – Pharmaceutical and Life Sciences) at Waters Corporation and Group Leader (Analytics) at S*BIO (a pharmaceutical joint venture between the Singapore Economic Development Board [EDB] and Chiron Corporation at Emeryville, California [currently Novartis]).